Abliva AB

4 Decision Makers · 6 Verified Contacts & Email Format

📍 Lund, Skane Lan, SwedenBiotechnology🗓 Est. 2000👥 Under 10 employees

About Abliva AB

Abliva develops medicines for the treatment of primary mitochondrial diseases.

Email Format

{first_name}.{last_name}@abliva.com — 100.0%

sarah.smith@abliva.com

Leadership & Decision Makers

Contact details of 4 Abliva AB decision makers

Ellen Wittmack Donnelly

CEO
  • Work email

    e************y@abliva.com

Dag Nesse

Vice President Clinical Operations

Catharina Jz. Johansson

CFO

Eskil Elmér

co-founder & CSO

Team & Specialists

Contact details of 2 Abliva AB team members

Eleonor Asander

  • Work email

    e*************r@abliva.com

Eleonor Åsander Frostner

R&D / Communications

General Emails

General company emails, e.g. customer support lines

    info@abliva.com

    General Inquiries

    admin@abliva.com

    Admin Team

    u003eir@abliva.com

    Investor Relations

    u003einfo@abliva.com

    General Inquiries

    ir@abliva.com

    Investor Relations

Similar Companies like Abliva AB

Kite Pharma

kitepharma.com
Biotechnology · Los Angeles, CA · Est. 2009 · 101–250 employees

HQ: Los Angeles, CA

Adimab

adimab.com
Biotechnology · Lebanon, New Hampshire, United States · Est. 2007 · 101–250 employees

HQ: Lebanon, New Hampshire, United States

Sorrento Therapeutics

sorrentotherapeutics.com
Pharmaceuticals · San Diego, CA · Est. 2006 · 101–250 employees · $500M–$1B

HQ: San Diego, CA

nference

nference.com
Biotechnology · Cambridge, MA · Est. 2013 · 251–500 employees

HQ: Cambridge, MA

Bavarian Nordic

bavarian-nordic.com
Biotechnology · Kvistgaard, Hovedstaden, Denmark · Est. 1994 · 251–500 employees

HQ: Kvistgaard, Hovedstaden, Denmark

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 27/07/2025

+46 (0)46-275 62 20

Lund, Skane Lan, Sweden

Specialization: Clinical Trials,
Legal Name: Abliva AB
Business Type: Public
Employees: 1-10
Rounds: Post-IPO Equity
Founded Date: 2000
Company Type: For Profit
Stock Symbol: STO:ABLI
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: +46 (0)46-275 62 20
Last Investment Activity: Dec 21, 2023
Investments Activity: Dec 21, 2023 Dec 15, 2023 Nov 17, 2023

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.